JVMIX
Price
$30.34
Change
+$0.27 (+0.90%)
Updated
Dec 3 closing price
Net Assets
24.51B
LMCPX
Price
$33.31
Change
+$0.42 (+1.28%)
Updated
Dec 3 closing price
Net Assets
1.13B
Interact to see
Advertisement

JVMIX vs LMCPX

Header iconJVMIX vs LMCPX Comparison
Open Charts JVMIX vs LMCPXBanner chart's image
JHancock Disciplined Value Mid Cap I
Price$30.34
Change+$0.27 (+0.90%)
VolumeN/A
Net Assets24.51B
Lord Abbett Mid Cap Stock P
Price$33.31
Change+$0.42 (+1.28%)
VolumeN/A
Net Assets1.13B
JVMIX vs LMCPX Comparison Chart in %
View a ticker or compare two or three
VS
JVMIX vs. LMCPX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMIX is a Buy and LMCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 24.5B vs. LMCPX (1.13B). JVMIX pays higher dividends than LMCPX: JVMIX (0.74) vs LMCPX (0.35). JVMIX was incepted earlier than LMCPX: JVMIX (29 years) vs LMCPX (28 years). LMCPX (1.22) is less costly to investors than JVMIX (0.86). LMCPX is a more actively managed with annual turnover of: 53.00 vs. JVMIX (49.00). LMCPX has a lower initial minimum investment than JVMIX: LMCPX (0) vs JVMIX (250000). JVMIX annual gain was more profitable for investors over the last year : -5.17 vs. LMCPX (-11.56). JVMIX return over 5 years is better than : 31.86 vs. LMCPX (21.28).
JVMIXLMCPXJVMIX / LMCPX
Total Expense Ratio0.851.2270%
Annual Report Gross Expense Ratio0.861.2270%
Fund Existence29 years28 years-
Gain YTD12.5793.127402%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets24.5B1.13B2,166%
Annual Yield % from dividends0.740.35208%
Returns for 1 year-5.17-11.5645%
Returns for 3 years15.0311.80127%
Returns for 5 years31.8621.28150%
Returns for 10 years50.9439.43129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RADX4.490.26
+6.03%
Radiopharm Theranostics Limited
KD26.300.66
+2.57%
Kyndryl Holdings
ELVN21.000.44
+2.14%
Enliven Therapeutics
SBXD10.53-0.01
-0.09%
SilverBox Corp IV
BTI57.51-0.42
-0.73%
British American Tobacco plc